Three primary AML samples (ELN 2022 risk: 1 favorable; 2 intermediate - AML2, AML7, and AML18; Supplementary Table 1) were transplanted into male immunodeficient NSG mice (n = 62). Here, RUNX3 is linked to acute myeloid leukemia.